遗传决定的CRP变异影响类风湿关节炎疾病活动度评估
研究评估了rs1205单核苷酸变异对RA患者临床疾病活动度评估(包括DAS28(CRP))的影响。在三个观察性队列(UKB、VARA、FORWARD Databank)中分析显示,TT基因型与较低的log调整血清CRP显著相关(UKB β -0.371,95%CI -0.381至-0.360,P<0.001),VARA中TT基因型DAS28(CRP)显著低于CC基因型(β -0.22,95%CI -0.44至-0.0027,P=0.047),TT基因型中6-8%被重新分类为异常CRP,3%从低疾病活动度重新分类为中疾病活动度。
要点
- rs1205 TT基因型与较低的CRP水平显著相关(UKB β -0.371,95%CI -0.381至-0.360,P<0.001)。
- VARA队列中TT基因型DAS28(CRP)显著低于CC基因型(β -0.22,95%CI -0.44至-0.0027,P=0.047)。
- TT基因型中6-8%被重新分类为异常CRP,3%从低疾病活动度重新分类为中疾病活动度。
核心结论
- CRP的rs1205 TT基因型与较低的CRP和DAS28(CRP)相关,遗传因素可独立于患者疾病活动度导致CRP差异并影响疾病活动度评估。
研究设计与样本
- 研究纳入三个观察性队列:英国生物银行(UKB)、退伍军人事务部RA登记处(VARA)和FORWARD Databank。
- 采用线性回归评估rs1205基因型对log调整血清CRP浓度的影响,调整性别、年龄和人群结构。
- 将UKB的回归系数转换为改良CRP和DAS28(CRP),并确定异常CRP(>0.8 mg/dl)及DAS28(CRP)疾病活动度组间的重新分类。
主要发现
- 在488 377名UKB参与者中,TT和CT基因型者log调整CRP显著低于CC基因型(β TT -0.371,95%CI -0.381至-0.360,P<0.001;β CT -0.173,95%CI -0.179至-0.167,P<0.001)。
- 在2597名VARA参与者中,TT基因型者DAS28(CRP)显著低于CC基因型(β -0.22,95%CI -0.44至-0.0027,P=0.047),CT基因型无显著差异。
- TT基因型者中6-8%被重新分类为异常CRP,3%从低疾病活动度重新分类为中疾病活动度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In patients with RA, we evaluated a single-nucleotide variant previously associated with lower CRP to assess if this impacts clinical disease activity assessments including the disease activity score-28 with CRP (DAS28(CRP)). METHODS: Patients from three observational cohorts were evaluated-the United Kingdom Biobank (UKB), the Veterans Affairs RA Registry (VARA) and the FORWARD Databank. The effect of rs1205 genotype on log-adjusted serum CRP concentrations was assessed using linear regression adjusted for sex, age and population structure. The regression coefficients from UKB were converted to create a modified CRP and DAS28(CRP). Reclassification to an abnormal CRP (>0.8 mg/dl) and between DAS28(CRP) disease activity groups were determined. RESULTS: Among the 488 377 UKB participants, individuals with the TT and CT genotype had a statistically significantly lower log-adjusted CRP compared with the CC genotype [β TT genotype: -0.371 (95% CI -0.381, -0.360), P < 0.001; β CT genotype: -0.173 (95% CI -0.179, -0.167), P < 0.001]. In the 2597 VARA participants, the DAS28(CRP) was significantly lower in the genotype TT compared with the CC genotype [β -0.22, (95% CI -0.44, -0.0027), P = 0.047], but not in the CT genotype. In those with the TT genotype, 6-8% were reclassified to having an abnormal CRP and 3% of patients were reclassified from low to moderate disease activity. CONCLUSION: The rs1205 TT genotype in CRP is associated with lower CRP and DAS28(CRP). Given the widespread use of CRP, this demonstrates that genetic factors, irrespective of an individual patient's disease activity, can cause differences in CRP that impact disease activity assessment.
引用
- Riley TR, Wheeler AM, Cannon GW, et al. Genetically-determined variation in CRP impacts disease activity assessment in rheumatoid arthritis. Rheumatology (Oxford). 2025. PMID: 40100756. doi:10.1093/rheumatology/keaf069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。